Company intelligence / Profile preview
Jemincare
Jiangxi, Chinajemincare.com ↗
- Ownership
- Private
- Employees
- ~12000
- Development stage
- Phase 2
01
Overview
Jemincare has multiple approved drugs in China and internationally, with recent approvals for 6 clinical trials for innovative drugs in cancer and kidney disease areas. The company has drugs that have received approval in China and the United States.
- Therapeutic areas
- OncologyPsychiatryNeurologyNephrology
- Modalities
- Small molecule drugsHerbal medicineMonoclonal antibodiesBispecific antibodiesBiological products
- Industry
- Pharma
02
Drug pipeline
16 assets15 more assets in the full pipeline.
Request access →03
Partnerships
GenentechRAPT Therapeutics
Beyond the preview
Go deeper on Jemincare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jemincare.